Spero Therapeutics Aktie
1,96
EUR
±0,00
EUR
+0,10
%
2,35
USD
±0,00
USD
±0,00
%
Werbung
Spero Therapeutics Aktie Analyse
| 09.02.18 | Spero Therapeutics Overweight | Cantor Fitzgerald | |
| 27.11.17 | Spero Therapeutics Outperform | Oppenheimer & Co. Inc. | |
| 27.11.17 | Spero Therapeutics Buy | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung